Robert A. Lenz, Head of R&D: Neumora Therapeutics NMRA Sell · Filed 24/09/19

Trade details

Type: Insider sale
Amount: $363,606.28
Shares · price: 30,788 sh · $11.81 a share
Held after: 339,205 sh
Stock: Neumora Therapeutics NMRA
Person: Robert A. LenzHead of R&D
Trade date: 24/09/17
Filed: 24/09/19
Days to filing: 2 days

Sold 8.3% of holdings

Share of holding sold: 8.3%

Neumora Therapeutics trades, last 26 weeks

What else happened in Neumora Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/18~24/10/17

Robert A. Lenz's recent trades

Robert A. LenzHead of R&D
Sell10b5-1 planNeumora Therapeutics
Sell10b5-1 plan
Neumora Therapeutics
NMRA
$9,375
5,614 sh
$9,375
Filed 25/02/20
Traded 25/02/18
Robert A. LenzOfficer
Planned sale10b5-1 planNeumora Therapeutics
Planned sale10b5-1 plan
Neumora Therapeutics
NMRA
$9,383
5,614 sh
$9,383
Filed 25/02/18
Traded 25/02/18
Robert A. LenzHead of R&D
Sell10b5-1 planNeumora Therapeutics
Sell10b5-1 plan
Neumora Therapeutics
NMRA
$124.6K
8,260 sh
$124.6K
Filed 24/10/11
Traded 24/10/10
Robert A. LenzHead of R&D
Sell10b5-1 planNeumora Therapeutics
Sell10b5-1 plan
Neumora Therapeutics
NMRA
$83.5K
5,563 sh
$83.5K
Filed 24/10/11
Traded 24/10/09
Robert A. LenzHead of R&D
Sell10b5-1 planNeumora Therapeutics
Sell10b5-1 plan
Neumora Therapeutics
NMRA
$129.1K
10,676 sh
$129.1K
Filed 24/09/19
Traded 24/09/18